Efficacy and safety of modified Yupingfeng formula in treating allergic rhinitis: A protocol for systematic review and meta analysis

BACKGROUND: Allergic rhinitis (AR) is a non-infectious chronic nasal mucosal disease mediated mainly by IgE, which affects 40% of the global population and has a recurrence rate of more than 50%. The modified Yupingfeng formula (MYPFF) is widely used in the treatment of allergic rhinitis in China. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Chao, Liu, Ting, Zeng, Zhen, Wang, Dandan, Tang, Guangjun, Wang, Huan, Tian, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748353/
https://www.ncbi.nlm.nih.gov/pubmed/33371114
http://dx.doi.org/10.1097/MD.0000000000023698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748353/
https://www.ncbi.nlm.nih.gov/pubmed/33371114
http://dx.doi.org/10.1097/MD.0000000000023698

Ejemplares similares